SUBSCRIBE
SUBSCRIBE

Immatics

NEWS
Business
Genmab and Immatics Partner on Next-Generation T-Cell Bispecific Immunotherapies Program
Denmark-based Genmab A/S struck a discovery and development deal with Immatics Biotechnologies GmbH.
July 12, 2018
 · 
2 min read
 · 
Alex Keown
Business
Biotech Leadership Transformations: Week of May 21
There have been a number of leadership changes in the life sciences industries over the past week. BioSpace compiled a roundup of the changing landscape of the c-suite and boards of directors across the industry.
May 28, 2018
 · 
4 min read
 · 
Alex Keown
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Immatics US Launches as Spinout of Immatics and MD Anderson Cancer Center
August 26, 2015
 · 
3 min read
Load More
JOBS
IN THE PRESS
Business
Immatics Announces Third Quarter 2022 Financial Results and Business Update
November 17, 2022
 · 
17 min read
Drug Development
Immatics Presents Comprehensive Preclinical Data Set for TCR Bispecific Candidate IMA402 Targeting PRAME at European Society for Medical Oncology (ESMO) Congress 2022
September 10, 2022
 · 
8 min read
Business
Immatics Announces First Quarter 2022 Financial Results and Business Update
June 2, 2022
 · 
14 min read
Drug Development
Immatics Initiates Phase 1 Clinical Trial to Evaluate Lead TCR Bispecific IMA401 in Patients with Advanced Solid Tumors
May 10, 2022
 · 
7 min read
Business
BioCopy AG and Immatics enter into a collaboration to characterize T cell receptor - peptide-HLA interactions
July 7, 2021
 · 
3 min read
Business
Immatics Announces Changes to its Board of Directors - May 26, 2021
May 26, 2021
 · 
2 min read
Drug Development
Immatics Presents Preclinical Proof-of-Concept Data for TCR Bispecifics Program IMA402 Targeting PRAME
May 11, 2021
 · 
6 min read
Business
Immatics Appoints Cedrik Britten as Chief Medical Officer
June 4, 2020
 · 
6 min read
Business
Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies
March 17, 2020
 · 
13 min read
Business
Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies
February 20, 2020
 · 
4 min read
Load More